image credit- shutterstock
4baseCare, a precision oncology company in India, has announced a collaboration with Cellworks Group, Inc., a US-based company and world leader in Personalized Medicine in the key therapeutic areas of Oncology and Immunology.
As a part of this association, the organisations will further their capabilities in personalised cancer care and treatment strategy based on advanced clinical insights through genomics-based molecular profiling and biosimulation.
The collaboration aims to deliver greater insights to the oncology fraternity, predict patient therapy responses and enable therapy selection resulting in optimal treatment outcomes.
4baseCare has developed a strong portfolio of Cancer gene panels to identify actionable insights for personalised cancer therapy. Within these, the TarGT Absolute test from 4baseCare is the most comprehensive test with a whole-exome and transcriptome approach to identify DNA and RNA alterations in 20,000 genes.
